We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (270)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (61)
- Manufacturing (51)
- Vaping hub (51)
- Labelling and packaging (34)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Import and export (24)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (4)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1245 result(s) found, displaying 501 to 525
-
Media releasesThe TGA has issued 12 infringement notices totalling $31,698 to a NSW based individual for alleged unlawful advertising of disposable nicotine vaping products on several websites.
-
Regulatory decision noticesThe TGA has issued a direction notice to Phenix Health Pty Ltd to cease alleged unlawful advertising of nicotine vaping products.
-
Media releasesThe TGA has provisionally approved a paediatric dose of the Moderna COVID-19 vaccine, SPIKEVAX, for use in individuals aged 6 months to less than 6 years (6 months to 5 years).
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesThe TGA is providing guidance on surrogate viruses that may be used to test disinfectants making claims of efficacy against Monkeypox.
-
News articlesCOVID-19 vaccines that have received a provisional determination from the TGA.
-
Media releasesOn 5 July 2022 the TGA granted two provisional determinations to Pfizer Australia Pty Ltd.
-
Media releasesPrecision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping products
-
Regulatory decision noticesDirection Notice issued to cease advertisement of prescription and illegal products
-
Media releasesOn 28 June 2022 the TGA granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, COMIRNATY.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has issued eight (8) infringement notices totalling $106,560 to Hough Pharma Pty Ltd for allegedly failing to provide information to the TGA to demonstrate the safety and performance of three COVID-19 RATs.
-
Regulatory decision noticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1992.
-
Regulatory decision noticesThis Order may be cited as Therapeutic Goods (Groups) Order No. 1 of 1992.
-
Regulatory decision noticesThis Order revokes Therapeutic Goods (Groups) Order No. 1 of 1991.
-
Media releasesThe TGA has commenced court proceedings in the Federal Court of Australia against Prefixx Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesWhen new safety information for medicines is identified, the Therapeutic Goods Administration (TGA) works with the sponsors to update Product Information (PI) to ensure that health professionals and consumers have access to this information.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe transition period from the 2018 to the 2021 Advertising Code ends 30 June 2022.
-
Media releasesThe TGA has issued one infringement notice totalling $2,664 to a Queensland based individual for alleged unlawful advertising of therapeutic goods in relation to COVID-19.